지적재산권의 ‘정당한 행사’의 판단기준과 역지불 합의의 경쟁법상 취급
The legal standard of the intellectual property rights and the reverse payment agreement in terms of the competition law regime
0
조회
0
다운로드
11
인용
0
참고문헌
키워드
초록
Both the intellectual property law and the competition law aim at promoting consumer welfare. Therefore the justification of the IP practice should be evaluate by means of competitive standard. The undertaking who produces the original drug with the relative patent and does not want competitors who make the generic drugs to enter the market set the reverse payment agreement with competitors. Through such agreement the undertaking prevents the competition of the market and can make use of monopoly power until the end of the patent. It hinder the free and fair competion of the market. Lubeck Case of the EU and Actavis judgement in the USA point out the anti-competitiveness of the reverse payment agreement. It should be regulated by the illegal cartel with the standard of rule of reason.
Abstract
Both the intellectual property law and the competition law aim at promoting consumer welfare. Therefore the justification of the IP practice should be evaluate by means of competitive standard. The undertaking who produces the original drug with the relative patent and does not want competitors who make the generic drugs to enter the market set the reverse payment agreement with competitors. Through such agreement the undertaking prevents the competition of the market and can make use of monopoly power until the end of the patent. It hinder the free and fair competion of the market. Lubeck Case of the EU and Actavis judgement in the USA point out the anti-competitiveness of the reverse payment agreement. It should be regulated by the illegal cartel with the standard of rule of reason.
참고문헌 (19)
- 권남훈, "역지불합의의 경쟁제한성 판단", 산업조직연구, 21(1), pp.59~94 (2013), 한국산업조직학회
- 권영준, "특허권 남용의 법리와 그 관련 문제", 산업재산권, (36), pp.175~226 (2011), 한국지식재산학회
- 김현수, "역지급 합의의 규제에 관한 연구", 비교사법, 18(3), pp.915~948 (2011), 한국비교사법학회
- 신혜은, "특허권자와 복제약 사업자의 역지불합의에 관한 연구 - 관련 미국판례와 공정거래위원회의 개정 심사지침을 중심으로 -", 산업재산권, (36), pp.39~80 (2011), 한국지식재산학회
- 윤성운, "역지불합의에 관한 한국, 유럽, 미국의 최근동향", 경쟁저널 (2011)
- 이황, "역지불 합의에 대한 미국 Actavis 판결과 시사점", 대법원 제93회 비교법실무연구회 발표자료 (2013)
- 차성민, "역지불합의의 위법성 판단", 사법, 1(22), pp.67~96 (2012), 사법발전재단
- 홍동표, "특허소송 합의에 대한 경쟁법 적용: reverse payment를 중심으로", 법경제학연구, 6(2), pp.183~198 (2009), 한국법경제학회
- 의약품 분야 지적재산권 관련 경쟁제한행위에 대한 외국사례 분석 및효과적인 법집행 방안 연구, "공정거래위원회", ~ (2009)
- Alexiadis, "European Commission proposes stricter EU antitrust rules on technology transfer", E.I.P.R, 35(7) (2013)
- Bellamy&Child, "European Union law of competition(7.ed.)" (2013)
- Cho, T., "Reverse payment settlements : the US Supreme court has finally agreed to resolve the issue", Marshall Review of Intellectual Property Law (2013)
- Hovenkamp, "Anticompeitive Settlement of Intellectual Property Disputes", Minnesota Law Review, pp.87~ (2003)
- Kaeseberg, "Intellectual Property, antitrust and cumulative innovation in the EU and the US" (2012), Hart Publishing
- Romano Subiotto QC, "Legal Assessment of Patent Settlement Agreements Containing “Reverse” Payments", Fordham IP Conference (2013)
- Sack, "Der spezifische Gegenstand von Immaterialguetterrechten als immanente Schranke des Art. 85 Abs, 1 EG-Vertrag bei Wettbewerbsbeschraenkungen in Lizenzvertraegen", Recht der International Wirtschaft, 43 (1997)
- Schmid, M., "Pharmaceutical reverse payment settlements- a European perspective in the wake of the sector inquiry", ECLR (2012)
- Executive Summary of the Pharmaceutical Sector Inquiry Report, "COMMUNICATION FROM THE COMMISSION", ~ (2009)
- EU Commission, "Assessment of potential anticompetitive conduct in the field of intellectual property rights and assessment of the interplay between competition policy and IPR protection" (2011)